BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26043680)

  • 1. Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.
    Grimmsmann T; Chenot JF; Angelow A
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):803-11. PubMed ID: 26043680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany.
    Icks A; Haastert B; Rathmann W; Schröder-Bernhardi D; Giani G
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):516-23. PubMed ID: 17907594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and status of nitrate therapy in East Germany].
    Engelmann L; Wetzler G; Kucher A; Frömmel H
    Z Kardiol; 1989; 78 Suppl 2():99-101; discussion 115-7. PubMed ID: 2511700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with NO donors-antiatherogenic and antioxidant actions].
    Grosser N; Schröder H
    Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial.
    Münzel T; Meinertz T; Tebbe U; Schneider HT; Stalleicken D; Wargenau M; Gori T; Klingmann I;
    Eur Heart J; 2014 Apr; 35(14):895-903. PubMed ID: 24071762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of short- and long-acting nitrates in stable angina pectoris.
    Kosmicki MA
    Curr Clin Pharmacol; 2009 May; 4(2):132-41. PubMed ID: 19442078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E; Aspe y Rosas J; Alcocer Diaz Barreiro L; Diaz Barreiro AL
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
    Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
    Kośmicki MA; Malczewska B; Sadowski Z
    Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PETN: long acting nitrate with tolerance devoiding properties and innovative potential].
    Richartz BM; Schneider HT; Silber S
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():43-7. PubMed ID: 18540332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term effect of various nitrates in ischemic heart disease and latent heart failure].
    Assmann I; Dueck KD
    Z Kardiol; 1989; 78 Suppl 2():68-71; discussion 115-7. PubMed ID: 2511696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C.
    Dikalov S; Fink B; Skatchkov M; Bassenge E
    Free Radic Biol Med; 1999 Jul; 27(1-2):170-6. PubMed ID: 10443933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effect of nitroglycerine and pentaerithritol compositum on exercise time restricted by anginal pain or objective parameters of ischaemia in patients with stable angina].
    Siński M; Lewandowski J; Abramczyk P; Nowosad H; Grzelak-Szafrańiska H
    Pol Arch Med Wewn; 2005 Aug; 114(2):755-60. PubMed ID: 16808313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentaerythrityl tetranitrate (PETN): a better nitrate?
    Rutherford E; Struthers AD
    Eur Heart J; 2019 Dec; 40(46):e23-e25. PubMed ID: 24126881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.